XML 99 R55.htm IDEA: XBRL DOCUMENT v3.20.4
Earnings (Loss) Per Common Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Basic EPS:                      
Net income (loss) $ (2,178) $ (2,399) $ (2,067) $ (2,241) $ 414 $ 425 $ 662 $ 185 $ (8,885) $ 1,686 $ 1,412
Weighted average common shares outstanding (in shares)         434,578 441,915 445,008 451,951 483,888 443,363 464,236
Basic EPS (in dollars per share)         $ 0.95 $ 0.96 $ 1.49 $ 0.41 $ (18.36) $ 3.80 $ 3.04
Diluted EPS:                      
Net income (loss) for purposes of computing diluted EPS                 $ (8,885) $ 1,686 $ 1,412
Share computation for diluted EPS:                      
Basic weighted average common shares outstanding (in shares)         434,578 441,915 445,008 451,951 483,888 443,363 464,236
Dilutive effect of stock awards (in shares)                 0 906 1,424
Diluted weighted average common shares outstanding (in shares)         435,659 442,401 445,587 453,429 483,888 444,269 465,660
Diluted EPS (in dollars per share)         $ 0.95 $ 0.96 $ 1.49 $ 0.41 $ (18.36) $ 3.79 $ 3.03
6.50% convertible senior notes                      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                      
Antidilutive securities (in shares)                 31,882 0 0
Restricted stock unit awards                      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                      
Antidilutive securities (in shares)                 4,584 2,520 1,266
Issuance of PSP1 Warrants (see Note 1(b))                      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                      
Antidilutive securities (in shares)                 349 0 0
Treasury Loan Warrants                      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                      
Antidilutive securities (in shares)                 107 0 0